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A previous study indicated a causal link between certain miRNAs
induced by obesity and the development of hepatic insulin resis-
tance and type 2 diabetes. Here we provide accompanying data
collected using Affymetrix GeneChip miRNAs microarrays to
identify the changes in miRNAs expression in the liver of mice fed
a high fat diet (HFD). Differentially expressed microRNA analyses
in the liver of the HFD-fed mice revealed a range of upregulated
(41.5-fold) or downregulated (o0.5-fold) miRNAs. Among those
upregulated miRNAs, in silico target analysis, such as TargetScan,
PicTar, and miRWalk, identiﬁed miRNAs with the putative binding
sites on the 3’UTRs of INSR and/or IRS-1. Interpretation of the data
and further extensive insights into the implication of miRNAs,
particularly miR-15b, in hepatic insulin resistance can be found in
"Obesity-induced miR-15b is linked causally to the development of
insulin resistance through the repression of the insulin receptor in
hepatocytes." (W.M. Yang, H.J. Jeong, S.W. Park, W. Lee, 2015)[1].
& 2016 The Authors. Published by Elsevier Inc. This is an open
access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).vier Inc. This is an open access article under the CC BY license
emistry, Dongguk University College of Medicine, Gyeongju 780-714,
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featuresDifferentially expressed miRNAs of the liver of mice fed with either a NFD or a
HFD were analyzed using Affymetrix GeneChip miRNA microarray.ata source
locationDongguk University School of Medicine, Gyeongju 780-714, Koreaata accessibility The data are available with this articleValue of the data
 The data can allow a prediction of the biological signiﬁcance of miRNAs associated with the
pathogenesis of obesity, insulin resistance and type 2 diabetes.
 The data can be compared with miRNA analysis from other cell or tissue types with obesity.
 Differentially expressed miRNAs in this dataset could be applied to further study the changes in the
cellular phenotype by high fat diet-induced obesity and metabolic diseases.
 The results support a previous study [1] and the use of transcriptomic technologies in non-model
organisms.1. Data
Diets rich in saturated fatty acids (SFA) can exacerbate obesity [2] and increase the risk of insulin
resistance. This condition is characterized by an inadequate response of the insulin-sensitive tissues
to insulin, leading to type 2 diabetes and metabolic syndrome [3]. Obesity modulates aberrantly the
expression of certain miRNAs targeting the mRNAs of the insulin signaling molecules, and participates
actively in the pathogenesis of insulin resistance [4,5]. A previous study reported that a high fat diet
(HFD) induces miR-15b in the liver of mice, which suppresses the expression of hepatic INSR, but not
IRS-1, by targeting INSR 3’UTR directly [1]. Therefore, certain types of miRNA induced by obesity can
be linked causally to the development of hepatic insulin resistance, which may in turn lead to type
2 diabetes. This study provides accompanying data collected using Affymetrix GeneChip microarrays
to identify the changes in miRNA expression in the liver of mice fed with a HFD for 14 weeks. Dif-
ferentially expressed miRNA analyses in the liver of HFD-fed mice showed that a range of miRNAs
were upregulated more than 1.5-fold (Supplement File. 1) or downregulated less than 0.5-fold
(Supplement File. 2). Among those differentially expressed miRNAs, the upregulated miRNAs may be
involved in the reduction of INSR and IRS-1 levels observed in the liver of HFD-fed mice. Therefore,
this study next examined whether the 3’UTRs of INSR and IRS-1 possess direct binding sites for the
upregulated miRNAs. In silico target analysis using TargetScan, PicTar, and miRWalk showed that a
range of certain miRNAs have putative binding sites for the 3’UTRs of INSR (Table 1) and/or IRS-1
(Table 2). An interpretation of the data and further extensive insights into the implication of miRNAs,
particularly miR-15b, in hepatic insulin resistance can be found elsewhere [1].
Table 1
miRNAs putatively targeting INSR.
miRNAs Fold change Accession Sequence
miR-15b-5p 1.62 MIMAT0000124 UAGCAGCACAUCAUGGUUUACA
miR-28a-5p 1.58 MIMAT0000653 AAGGAGCUCACAGUCUAUUGAG
miR-28a-3p 1.86 MIMAT0004661 CACUAGAUUGUGAGCUGCUGGA
miR-132-3p 2.15 MIMAT0000144 UAACAGUCUACAGCCAUGGUCG
miR-140-3p 1.73 MIMAT0000152 UACCACAGGGUAGAACCACGG
miR-149-5p 16.27 MIMAT0000159 UCUGGCUCCGUGUCUUCACUCCC
miR-151-3p 1.93 MIMAT0000161 CUAGACUGAGGCUCCUUGAGG
miR-181a-5p 2.21 MIMAT0000210 AACAUUCAACGCUGUCGGUGAGU
miR-183-5p 1.51 MIMAT0000212 UAUGGCACUGGUAGAAUUCACU
miR-193a-5p 1.77 MIMAT0004544 UGGGUCUUUGCGGGCAAGAUGA
miR-212-3p 3.23 MIMAT0000659 UAACAGUCUCCAGUCACGGCCA
miR-292b-5p 2.83 MIMAT0029864 ACUCAAAACCUGGCGGCACUUUU
miR-296-3p 1.78 MIMAT0004576 GAGGGUUGGGUGGAGGCUCUCC
miR-322-5p 1.64 MIMAT0000548 CAGCAGCAAUUCAUGUUUUGGA
miR-326-3p 2.04 MIMAT0000559 CCUCUGGGCCCUUCCUCCAGU
miR-330-3p 2.35 MIMAT0000569 GCAAAGCACAGGGCCUGCAGAGA
miR-330-5p 1.62 MIMAT0004642 UCUCUGGGCCUGUGUCUUAGGC
miR-342-3p 1.50 MIMAT0000590 UCUCACACAGAAAUCGCACCCGU
miR-375-3p 1.51 MIMAT0000739 UUUGUUCGUUCGGCUCGCGUGA
miR-376c-3p 1.86 MIMAT0003183 AACAUAGAGGAAAUUUCACGU
miR-378a-3p 1.54 MIMAT0003151 ACUGGACUUGGAGUCAGAAGG
miR-383-5p 1.66 MIMAT0000748 AGAUCAGAAGGUGACUGUGGCU
miR-410-3p 1.51 MIMAT0001091 AAUAUAACACAGAUGGCCUGU
miR-421-3p 1.57 MIMAT0004869 AUCAACAGACAUUAAUUGGGCGC
miR-455-3p 2.71 MIMAT0003742 GCAGUCCACGGGCAUAUACAC
miR-455-5p 1.53 MIMAT0003485 UAUGUGCCUUUGGACUACAUCG
miR-532-3p 3.81 MIMAT0004781 CCUCCCACACCCAAGGCUUGCA
miR-532-5p 1.62 MIMAT0002889 CAUGCCUUGAGUGUAGGACCGU
miR-1224-5p 3.40 MIMAT0005460 GUGAGGACUGGGGAGGUGGAG
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2.1. Animals and high fat diet (HFD)-induced obesity
All The Animal Use and Care Committee at Dongguk University approved all experimental pro-
cedures involving mice. The C57BL/6N male mice were purchased from OrientBio (Seongnam,
Gyeonggi, Korea). They were maintained in a temperature (20–22 °C) and humidity (55710%) con-
trolled facility with a 12:12 h light–dark cycle and given access to food and water ad libitum. At
6 weeks of age, the mice were fed either a normal fat diet (NFD, 12.4% calories from fat; Purina,
Wilkes-Barre, PA, USA) or a HFD (60% calories from fat; Dyets Inc., Bethlehem, PA, USA) for 14 weeks.
During the experimental period, the body weights of the mice were recorded weekly. At the end of
the experiment, mice were fasted for 12 h and sacriﬁced by a cervical dislocation. The liver was
removed rapidly, washed with cold PBS, and subjected to RNA extraction.2.2. RNA extraction and quality check
The total RNA from the liver of mice was extracted using a miRNeasy Mini Kit (Qiagen) according
to the manufacturer's instructions. The purity and integrity of the RNA extracted were assessed using
a ND-1000 Spectrophotometer (NanoDrop) and Agilent 2100 Bioanalyzer (Agilent Technologies).
Equal amounts of RNA from ﬁve mice were combined and used for the microarray.
Table 2
miRNAs putatively targeting IRS-1.
miRNAs Fold change Accession Sequence
miR-15b-5p 1.62 MIMAT0000124 UAGCAGCACAUCAUGGUUUACA
miR-28a-3p 1.86 MIMAT0004661 CACUAGAUUGUGAGCUGCUGGA
miR-92b-3p 2.81 MIMAT0004899 UAUUGCACUCGUCCCGGCCUCC
miR-125a-5p 2.15 MIMAT0000135 UCCCUGAGACCCUUUAACCUGUGA
miR-149-5p 16.27 MIMAT0000159 UCUGGCUCCGUGUCUUCACUCCC
miR-151-5p 1.66 MIMAT0004536 UCGAGGAGCUCACAGUCUAGU
miR-155-5p 1.76 MIMAT0000165 UUAAUGCUAAUUGUGAUAGGGGU
miR-181a-5p 2.21 MIMAT0000210 AACAUUCAACGCUGUCGGUGAGU
miR-181b-5p 2.96 MIMAT0000673 AACAUUCAUUGCUGUCGGUGGGU
miR-181d-5p 1.52 MIMAT0004324 AACAUUCAUUGUUGUCGGUGGGU
miR-183-5p 1.51 MIMAT0000212 UAUGGCACUGGUAGAAUUCACU
miR-200c-3p 1.51 MIMAT0000657 UAAUACUGCCGGGUAAUGAUGGA
miR-296-3p 1.78 MIMAT0004576 GAGGGUUGGGUGGAGGCUCUCC
miR-322-5p 1.64 MIMAT0000548 CAGCAGCAAUUCAUGUUUUGGA
miR-325-3p 1.55 MIMAT0004640 UUUAUUGAGCACCUCCUAUCAA
miR-328-3p 2.20 MIMAT0000565 CUGGCCCUCUCUGCCCUUCCGU
miR-330-3p 2.35 MIMAT0000569 GCAAAGCACAGGGCCUGCAGAGA
miR-339-5p 2.13 MIMAT0000584 UCCCUGUCCUCCAGGAGCUCACG
miR-340-5p 1.54 MIMAT0004651 UUAUAAAGCAAUGAGACUGAUU
miR-342-3p 1.50 MIMAT0000590 UCUCACACAGAAAUCGCACCCGU
miR-370-3p 1.51 MIMAT0001095 GCCUGCUGGGGUGGAACCUGGU
miR-375-3p 1.51 MIMAT0000739 UUUGUUCGUUCGGCUCGCGUGA
miR-376c-3p 1.86 MIMAT0003183 AACAUAGAGGAAAUUUCACGU
miR-383-5p 1.66 MIMAT0000748 AGAUCAGAAGGUGACUGUGGCU
miR-410-3p 1.51 MIMAT0001091 AAUAUAACACAGAUGGCCUGU
miR-421-3p 1.57 MIMAT0004869 AUCAACAGACAUUAAUUGGGCGC
miR-423-3p 1.86 MIMAT0003454 AGCUCGGUCUGAGGCCCCUCAGU
miR-455-3p 2.71 MIMAT0003742 GCAGUCCACGGGCAUAUACAC
miR-455-5p 1.53 MIMAT0003485 UAUGUGCCUUUGGACUACAUCG
miR-466c-5p 2.09 MIMAT0004877 UGAUGUGUGUGUGCAUGUACAUAU
miR-466i-5p 1.78 MIMAT0017325 UGUGUGUGUGUGUGUGUGUG
miR-466m-5p 1.78 MIMAT0014882 UGUGUGCAUGUGCAUGUGUGUAU
miR-500-3p 2.29 MIMAT0003507 AAUGCACCUGGGCAAGGGUUCA
miR-501-3p 1.73 MIMAT0003509 AAUGCACCCGGGCAAGGAUUUG
miR-532-5p 1.62 MIMAT0002889 CAUGCCUUGAGUGUAGGACCGU
miR-669a-5p 2.31 MIMAT0003477 AGUUGUGUGUGCAUGUUCAUGUCU
miR-669f-5p 1.87 MIMAT0017327 AGUUGUGUGUGCAUGUGCAUGUGU
miR-669k-5p 1.85 MIMAT0017323 UGUGCAUGUGUGUAUAGUUGUGUGC
miR-669l-5p 1.87 MIMAT0009418 AGUUGUGUGUGCAUGUAUAUGU
miR-669m-5p 1.78 MIMAT0017346 UGUGUGCAUGUGCAUGUGUGUAU
miR-669p-5p 2.31 MIMAT0014889 AGUUGUGUGUGCAUGUUCAUGUCU
miR-1197-3p 1.51 MIMAT0005858 UAGGACACAUGGUCUACUUCU
miR-3102-5p 1.79 MIMAT0014933 GUGAGUGGCCAGGGUGGGGCUG
miR-3102-5p.2-5p 1.88 MIMAT0014934 GGUGGUGCAGGCAGGAGAGCC
miR-3473a 1.77 MIMAT0015645 UGGAGAGAUGGCUCAGCA
miR-3473b 1.71 MIMAT0020367 GGGCUGGAGAGAUGGCUCAG
miR-3473d 2.35 MIMAT0020632 CCACUGAGCCACUUUCCAGCCCUU
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The total RNA from the liver of the mice described above was prepared and subjected to the
Affymetrix Genechip miRNA 4.0 array (Affymetrix) process according to the Affymetrix technical
instructions. Brieﬂy, 600ng of RNAwas labeled with a FlashTag™ Biotin RNA Labeling Kit (Genisphere,
Hatﬁeld, PA, USA). The labeled RNA was quantiﬁed, fractionated, and hybridized to the miRNA
microarray provided by the manufacture. The labeled RNA was heated to 99 °C for 5 min and incu-
bated to 45 °C for 5 min. RNA-array hybridization was conducted with agitation at 60 rpm for 16 h at
48 °C on an Affymetrix
s
450 Fluidics Station. The chips were stained using a Genechip Fluidics Station
W.-M. Yang et al. / Data in Brief 9 (2016) 1155–1159 1159450 (Affymetrix), and scanned with an Affymetrix GCS 3000 scanner (Affymetrix). All signals were
normalized using the quantile method after a log2 transformation to make them comparable across
the microarrays.
2.4. Data extraction and in silico analysis
Differentially expressed miRNAs were analyzed automatically using Affymetrix
s
GeneChip™
Command Console software according to the Affymetrix data extraction protocol and identiﬁed by
calculating the fold change of either a NFD-fed mice versus a HFD-fed mice. The differentially
expressed miRNAs putatively targeting INSR 3’UTR and IRS-1 3’UTR were screened computationally
using publicly available algorithms (TargetScan: www.targetscan.org, Pictar: pictar.mdc-berlin.de, and
miRWalk: www.umm.uni-heidelberg.de).Acknowledgments
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